# Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

> **NCT00183950** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Southern California** · enrollment: 12 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Noscapine

## Key facts

- **NCT ID:** NCT00183950
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-03
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** No funding
- **Last updated:** 2014-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183950, "Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00183950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*